Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 2/20 | 0.38 |
| ▸ | KCNQ4 | P56696 | 3/20 | 0.37 |
| ▸ | KCNQ5 | Q9NR82 | 3/20 | 0.37 |
| ▸ | ATR | Q13535 | 1/20 | 0.36 |
| ▸ | LCK | P06239 | 4/20 | 0.36 |
| ▸ | SYK | P43405 | 1/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CTSS | P25774 | 2/20 | 0.33 |
| ▸ | CTSK | P43235 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30418571 | 1.00 | CYP17A1 (0.38) | CYP17A1KCNQ4KCNQ5ATRLCK | |
| SCHEMBL30380150 | 0.86 | ATR (0.40) | CYP17A1KCNQ4KCNQ5ATRLCK | |
| SCHEMBL26426350 | 0.86 | ATR (0.40) | CYP17A1KCNQ4KCNQ5ATRLCK | |
| SCHEMBL30747459 | 0.83 | AAK1 (0.37) | LMNAPOLBAAK1CA1CA2 | |
| SCHEMBL8280454 | 0.81 | ALDH1A1 (0.49) | ATRAAK1CA1CA2 | |
| SCHEMBL6578598 | 0.81 | HDAC1 (0.38) | CYP17A1KCNQ4KCNQ5ATRLCK | |
| SCHEMBL25829281 | 0.80 | CYP17A1 (0.43) | CYP17A1KCNQ4KCNQ5SYKRXFP1 | |
| SCHEMBL4922310 | 0.79 | LMNA (0.43) | CYP17A1ATRLCKSYKRXFP1 | |
| SCHEMBL30380330 | 0.79 | LMNA (0.43) | CYP17A1ATRLCKSYKRXFP1 | |
| SCHEMBL26093607 | 0.78 | SMN1; SMN2 (0.38) | POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023067353-A1 | HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | ARTIOS PHARMA LIMITED (GB) | 2023-04-27 | — | — | WO | disclosed |